Glaukos Corporation

GKOS Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government

Chart provided by TradingView

Income
Balance Sheet
Cash Flow
GKOS Income Statement
GKOS Balance Sheet
GKOS Cash Flow
Congress Trading

Recent trades of GKOS by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
GKOS Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
GKOS Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
GKOS Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by GKOS's directors and management

Corporate Lobbying

Government lobbying spending instances

  • $70,000 Oct 11, 2024 Issue: Medicare/Medicaid Taxation/Internal Revenue Code
  • $70,000 Jul 15, 2024 Issue: Taxation/Internal Revenue Code
  • $20,000 Apr 17, 2024 Issue: Medicare/Medicaid Health Issues
  • $20,000 Oct 20, 2023 Issue: Medicare/Medicaid Health Issues
  • $20,000 Jul 20, 2023 Issue: Medicare/Medicaid Health Issues
  • $20,000 Apr 17, 2023 Issue: Medicare/Medicaid Health Issues
  • $20,000 Jan 18, 2023 Issue: Medicare/Medicaid Health Issues
  • $20,000 Oct 20, 2022 Issue: Medicare/Medicaid Health Issues
  • $20,000 Jul 20, 2022 Issue: Medicare/Medicaid Health Issues
  • $20,000 Apr 18, 2022 Issue: Medicare/Medicaid Health Issues
  • $30,000 Jan 19, 2022 Issue: Medicare/Medicaid Health Issues
  • $20,000 Jan 18, 2022 Issue: None
  • $20,000 Oct 23, 2021 Issue: None
  • $30,000 Oct 20, 2021 Issue: Health Issues Medicare/Medicaid
  • $20,000 Jul 22, 2021 Issue: None
  • $30,000 Jul 20, 2021 Issue: Health Issues Medicare/Medicaid
  • $20,000 Apr 20, 2021 Issue: HEALTH ISSUES
  • $20,000 Apr 20, 2021 Issue: Health Issues Medicare/Medicaid
  • $20,000 Jan 20, 2021 Issue: HEALTH ISSUES
  • $20,000 Oct 20, 2020 Issue: HEALTH ISSUES
  • $20,000 Jul 20, 2020 Issue: HEALTH ISSUES
  • $20,000 Apr 20, 2020 Issue: HEALTH ISSUES
  • $20,000 Jan 23, 2020 Issue: HEALTH ISSUES
  • $50,000 Jan 21, 2020 Issue: Medical/Disease Research/Clinical Labs Health Issues
  • $20,000 Oct 18, 2019 Issue: Health Issues
  • $50,000 Oct 16, 2019 Issue: Medical/Disease Research/Clinical Labs Health Issues
  • $20,000 Jul 12, 2019 Issue: Health Issues
  • $50,000 Jul 09, 2019 Issue: Health Issues Medical/Disease Research/Clinical Labs
  • $50,000 Apr 17, 2019 Issue: Health Issues
  • $20,000 Apr 04, 2019 Issue: Health Issues
  • $50,000 Jan 19, 2019 Issue: Medical/Disease Research/Clinical Labs Health Issues
  • $20,000 Jan 09, 2019 Issue: Health Issues
  • $50,000 Oct 19, 2018 Issue: Medical/Disease Research/Clinical Labs Health Issues
  • $20,000 Oct 10, 2018 Issue: Health Issues
  • $50,000 Jul 18, 2018 Issue: Medical/Disease Research/Clinical Labs Health Issues
  • $10,000 Jul 11, 2018 Issue: Health Issues
  • $50,000 Apr 20, 2018 Issue: Medical/Disease Research/Clinical Labs
  • $50,000 Jan 20, 2018 Issue: Medical/Disease Research/Clinical Labs
  • $50,000 Oct 19, 2017 Issue: Medical/Disease Research/Clinical Labs
  • $50,000 Jul 18, 2017 Issue: Medical/Disease Research/Clinical Labs
  • $50,000 Apr 18, 2017 Issue: Medical/Disease Research/Clinical Labs
  • $20,000 Jan 16, 2017 Issue: Medical/Disease Research/Clinical Labs
  • $10,000 Jan 20, 2016 Issue: Health Issues
  • $20,000 Oct 20, 2015 Issue: Health Issues
  • $20,000 Jul 17, 2015 Issue: Health Issues
Corporate Lobbying

Estimated quarterly lobbying spending

U.S. Patents

New patents grants

  • Patent Title: Rho kinase inhibitor releasing implants and related methods of use Aug. 20, 2024
  • Patent Title: Implants with controlled drug delivery features and methods of using same May. 28, 2024
  • Patent Title: System and method for delivering multiple ocular implants Apr. 02, 2024
  • Patent Title: Drug delivery implants with bi-directional delivery capacity Mar. 12, 2024
  • Patent Title: Formulations Jan. 16, 2024
  • Patent Title: Intraocular physiological sensor Jan. 02, 2024
  • Patent Title: Gonioscopic devices Nov. 28, 2023
  • Patent Title: Gonioscopes Sep. 05, 2023
  • Patent Title: Intraocular physiological sensor Jul. 18, 2023
  • Patent Title: Punctal implants with controlled drug delivery features and methods of using same Jan. 31, 2023
  • Patent Title: Intraocular physiological sensor Jan. 31, 2023
  • Patent Title: Glaucoma stent and methods thereof for glaucoma treatment Jan. 24, 2023
  • Patent Title: Systems and methods for delivering an ocular implant to the suprachoroidal space within an eye Dec. 13, 2022
  • Patent Title: Systems and methods for delivering multiple ocular implants Jul. 05, 2022
  • Patent Title: Intraocular physiological sensor Jun. 21, 2022
  • Patent Title: System and method for delivering multiple ocular implants Dec. 14, 2021
  • Patent Title: Implant delivery apparatus Dec. 14, 2021
  • Patent Title: Apparatus and method for controlling placement of intraocular implants Sep. 14, 2021
  • Patent Title: Gonioscopic devices Jun. 01, 2021
  • Patent Title: Implants with controlled drug delivery features and methods of using same Mar. 30, 2021
  • Patent Title: Intraocular physiological sensor Dec. 01, 2020
  • Patent Title: Ocular implant delivery system and methods thereof Nov. 10, 2020
  • Patent Title: Uveoscleral shunt and methods for implanting same Nov. 10, 2020
  • Patent Title: Implant delivery apparatus Nov. 10, 2020
  • Patent Title: Gonioscopes Jun. 09, 2020
  • Patent Title: Gonioscope Jun. 09, 2020
  • Patent Title: Stent for treating ocular disorders Feb. 25, 2020
  • Patent Title: Glaucoma stent and methods thereof for glaucoma treatment Dec. 31, 2019
  • Patent Title: Gonioscopic devices Dec. 10, 2019
  • Patent Title: Shunt device and method for treating ocular disorders Dec. 03, 2019
  • Patent Title: System and method for treating an ocular disorder Nov. 26, 2019
  • Patent Title: Devices and methods for glaucoma treatment Nov. 26, 2019
  • Patent Title: Ocular system with anchoring implant and therapeutic agent Sep. 10, 2019
  • Patent Title: Implant delivery system and methods thereof for treating ocular disorders May. 14, 2019
  • Patent Title: Systems and methods for delivering an ocular implant to the suprachoroidal space within an eye May. 14, 2019
  • Patent Title: System and method for delivering multiple ocular implants Apr. 30, 2019
  • Patent Title: Implant delivery apparatus Apr. 23, 2019
  • Patent Title: Anterior chamber drug-eluting ocular implant Apr. 02, 2019
  • Patent Title: Systems and methods for delivering an ocular implant to the suprachoroidal space within an eye Jan. 29, 2019
  • Patent Title: Gonioscope Nov. 06, 2018
  • Patent Title: System and method for treating an ocular disorder Jun. 12, 2018
  • Patent Title: Ocular implant delivery systems Jun. 05, 2018
  • Patent Title: Uveoscleral shunt and methods for implanting same May. 08, 2018
  • Patent Title: Shunt device and method for treating ocular disorders Nov. 28, 2017
  • Patent Title: Intraocular physiological sensor Aug. 15, 2017
  • Patent Title: Devices and methods for glaucoma treatment Mar. 21, 2017
  • Patent Title: Systems and methods for delivering an ocular implant to the suprachoroidal space within an eye Mar. 14, 2017
  • Patent Title: Ocular disorder treatment methods and systems Feb. 21, 2017
  • Patent Title: Implant delivery system and methods thereof for treating ocular disorders Feb. 07, 2017
  • Patent Title: System and method for delivering multiple ocular implants Jan. 31, 2017
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded from public contracts

WallStreetBets

Number of mentions of GKOS in WallStreetBets Daily Discussion

GKOS News

Recent insights relating to GKOS

CNBC Recommendations

Recent picks made for GKOS stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in GKOS

GKOS Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view GKOS Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top